Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Harvard Business School
Moodys
McKinsey
Johnson and Johnson

Last Updated: June 27, 2022

Novadaq Tech Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NOVADAQ TECH, and when can generic versions of NOVADAQ TECH drugs launch?

NOVADAQ TECH has one approved drug.

There are five US patents protecting NOVADAQ TECH drugs.

There are fifty-one patent family members on NOVADAQ TECH drugs in eleven countries.

Summary for Novadaq Tech
International Patents:51
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Novadaq Tech

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes 9,421,280 See Plans and Pricing See Plans and Pricing
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes 8,647,605 See Plans and Pricing See Plans and Pricing
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes 8,185,176 See Plans and Pricing See Plans and Pricing
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes 8,406,860 See Plans and Pricing See Plans and Pricing
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes 10,631,746 See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Novadaq Tech

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 6,915,154 See Plans and Pricing
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 8,892,190 See Plans and Pricing
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 7,881,777 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for Novadaq Tech Drugs

Country Patent Number Estimated Expiration
European Patent Office 2268201 See Plans and Pricing
European Patent Office 2989976 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2009127972 See Plans and Pricing
Japan 5476317 See Plans and Pricing
Canada 2811847 See Plans and Pricing
Japan 2017534361 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2012038824 See Plans and Pricing
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Mallinckrodt
Harvard Business School
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.